Sign in
Taking people in United StatesNo phase

Focused ultrasound treatment for movement problems in dyskinetic cerebral palsy

Tests focused ultrasound on a brain area in young people with dyskinetic cerebral palsy.

Key facts

Who runs it
Children's National Research Institute
Where
Washington D.C., United StatesSee the site
Trial code
Registry title
Focused Ultrasound Pallidotomy for Dyskinetic Cerebral Palsy in Pediatric and Young Adult Subjects
Status
Recruiting
People taking part
10 people, planned
Started
26 Jan 2024
Expected to end
Aug 2028
Type of study
Interventional
Treatments tested
  • Focused Ultrasound Pallidotomy
Record updated
11 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children and young adults with dystonia (uncontrolled twisting movements) caused by dyskinetic cerebral palsy. Their doctor has chosen GPi-DBS or pallidotomy, and they have chosen pallidotomy, here done with focused ultrasound.

Age
8 to 22 years
Sex
All sexes
Disease stage
Secondary dystonia due to cerebral palsy caused by lack of oxygen around birth (perinatal hypoxic injury). Brain areas globus pallidus internus and thalamus must look intact on MRI.
Earlier treatment
Medicines against dystonia have not helped enough. Dystonia medicines must have been stable for the last 30 days.
Biomarker or test result
Skull Density Ratio (SDR) of 0.40 or more. Head circumference of at least 49cm (19 in).

Main reasons for not taking part

  • Primary (for example DYT1) or idiopathic dystonia
  • Severe spasticity (Modified Ashworth Scale >3), fixed hemi-dystonia or total loss of head control
  • Other severe brain disease, such as brain tumor or neurodegenerative disease
  • DBS leads in place, or a condition likely to need MRI in the future
  • Pregnancy, breastfeeding, or blood thinners that cannot be stopped around surgery

The registry criteria, word for word

Show all 35 criteriaShow less

Who can take part

  • The treating physician has chosen GPi-DBS or pallidotomy for the treatment of the secondary dystonia caused by cerebral palsy in this patient
  • Patient and/or legal representative, if the patient is underaged or not capable to give consent himself, have chosen pallidotomy as treatment
  • The consent to participate in the trial of the underaged patient, if he is capable to understand the study requirements, is required
  • Age at enrolment 8-22 years
  • Diagnosis of secondary dystonia due to cerebral palsy caused by perinatal hypoxic injury
  • Anti-dystonic pharmacotherapy insufficient
  • Stable anti-dystonic medication over the last 30 days
  • Globus pallidus internus (pars posterior) and thalamus (motor part) intact on MRI (not older than 2 years - if possible)
  • No fixed severe skeletal deformations with loss of function, which need immediate orthopaedic surgical intervention
  • Sufficient compliance of the patient or the legal representative if the patient is underaged or not capable to give consent himself to take part in the study
  • Informed consent to take part in the study from patient and/or legal representative if the patient is underaged or not capable to give consent himself
  • Patient and/or legal representative if the patient is underaged or not capable to give consent himself, understands the study requirements and the treatment procedures and provides written informed consent before any study-specific tests or procedures are performed

Who cannot take part

  • Severe axial hypotonia with total loss of head control (e.g. absence of control at "upper thoracic level" in the SATCo score) (medication effect excluded)
  • Fixed severe skeletal contractions with loss of function which require immediate orthopaedic surgical intervention
  • Patients with other severe concurrent neurological disease (e. g. brain tumor, neurodegenerative diseases, trauma etc.)
  • Any findings in neuropsychological screening assessments that would contraindicate DBS surgery
  • Any current drug and / or alcohol abuse
  • Any other active implanted device (e.g. Cochlear implant, pacemaker), whether turned on or off, would be allowed provided that they do not interfere with functioning of the device
  • Currently on any anticoagulant medications that cannot be discontinued during perioperative period
  • Participation in another drug, device, or biologics trial concurrently or within the preceding 30 days; any other trial participation should be approved by the Principal Investigator
  • Condition likely to require use of MRI in the future
  • Any intracranial abnormality or medical condition that would contraindicate DBS surgery
  • Any history of frequent grand-mal seizures without response to anticonvulsive treatment
  • A history of neurostimulation intolerance in any area of the body
  • Any significant medical condition that is likely to interfere with study procedures or likely to confound evaluation of study endpoints, including any terminal illness with survival <24 months
  • Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the subject or the quality of the data
  • Patients with known primary (e.g. DYT1) or idiopathic dystonia
  • Fixed hemi-dystonia
  • Severe spasticity in knee- and elbow-flexors and -extensors (Modified Ashworth Scale >3)
  • The presence of DBS leads due the risks of these ferromagnetic devices in the MRI environment
  • A female that is breastfeeding or of childbearing potential with a positive urine pregnancy test or - if a person is sexually active - not using sufficient contraception with a Pearl Index of less than 1% including all forms of hormonal contraception ("antibaby-pill", hormonal plaster, NuvaRing®, Implanon®, hormonal depot injections, contraceptive coil), the tubal ligature (female sterilization). Alternatively, the female of child bearing potential is sexually abstinent
  • Subjects who have contraindications to anesthesia, in the judgment of the attending anesthesiologist
  • Subjects who are unwilling or unable to undergo general anesthesia
  • Minimum head circumference < 49cm
  • Skull Density Ratio (SDR) <0.40

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 8 and 22 years old?

Where in United States

  • Children's National HospitalWashington D.C., United StatesContact: Chima Oluigbo, MDTaking people

About the trial

What the trial wants to find out

The primary objective of the proposed study is to evaluate the safety of ExAblate Transcranial MRgFUS as a tool for creating bilateral or unilateral lesions in the globus pallidus (GPi) in patients with treatment-refractory secondary dystonia due to dyskinetic cerebral palsy

The group in the trial

  • Focused Ultrasound PallidotomyTreatment being tested

    Pediatric and young adult patients between ages of 8 and 22 years with pharmaco-resistant secondary dystonia due to dyskinetic cerebral palsy who have Focused Ultrasound Pallidotomy

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Safety and Impact on Quality of Life of Focused Ultrasound Pallidotomy for Dyskinetic Cerebral Palsy in Pediatric and Young Adult Subjects
Plain-language title
Focused ultrasound treatment for movement problems in dyskinetic cerebral palsyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT06036199, who can take part
Record updated
11 June 2026